Lapinig, Benita D.

HRN: 00-55-95  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2022
CEFTRIAXONE 1G (VIAL)
08/03/2022
08/09/2022
IV
2g
Q24
CAP MR
Waiting Final Action 
08/03/2022
AZITHROMYCIN 500MG TABLET (TAB)
08/03/2022
08/09/2022
ORAL
500mg
OD
CAP MR
Waiting Final Action 
08/03/2022
REMDESIVIR 100MG (VIAL)
08/03/2022
08/08/2022
IV
100mg
Q24
Covid Severe
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: